Open Access

[Retracted] Isoquercitrin inhibits bladder cancer progression in vitro and in vivo by regulating the PI3K/Akt and PKC signaling pathways

  • Authors:
    • Feng Chen
    • Xiaochi Chen
    • Deyong Yang
    • Xiangyu Che
    • Jianbo Wang
    • Xiancheng Li
    • Zhiwei Zhang
    • Qifei Wang
    • Wei Zheng
    • Lina Wang
    • Xuejian Wang
    • Xishuang Song
  • View Affiliations

  • Published online on: December 18, 2023     https://doi.org/10.3892/or.2023.8684
  • Article Number: 25
  • Copyright : © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

February-2024
Volume 51 Issue 2

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Chen F, Chen X, Yang D, Che X, Wang J, Li X, Zhang Z, Wang Q, Zheng W, Wang L, Wang L, et al: [Retracted] Isoquercitrin inhibits bladder cancer progression <em>in vitro</em> and <em>in vivo</em> by regulating the PI3K/Akt and PKC signaling pathways. Oncol Rep 51: 25, 2024
APA
Chen, F., Chen, X., Yang, D., Che, X., Wang, J., Li, X. ... Song, X. (2024). [Retracted] Isoquercitrin inhibits bladder cancer progression <em>in vitro</em> and <em>in vivo</em> by regulating the PI3K/Akt and PKC signaling pathways. Oncology Reports, 51, 25. https://doi.org/10.3892/or.2023.8684
MLA
Chen, F., Chen, X., Yang, D., Che, X., Wang, J., Li, X., Zhang, Z., Wang, Q., Zheng, W., Wang, L., Wang, X., Song, X."[Retracted] Isoquercitrin inhibits bladder cancer progression <em>in vitro</em> and <em>in vivo</em> by regulating the PI3K/Akt and PKC signaling pathways". Oncology Reports 51.2 (2024): 25.
Chicago
Chen, F., Chen, X., Yang, D., Che, X., Wang, J., Li, X., Zhang, Z., Wang, Q., Zheng, W., Wang, L., Wang, X., Song, X."[Retracted] Isoquercitrin inhibits bladder cancer progression <em>in vitro</em> and <em>in vivo</em> by regulating the PI3K/Akt and PKC signaling pathways". Oncology Reports 51, no. 2 (2024): 25. https://doi.org/10.3892/or.2023.8684